Free tool
Stocks far below their 52-week high
We cover 4 companies trading at least 50% below their own 52-week high. The median market value in the group is $135.85M. Across the group, the median move over the past trading day is +4.55%. Price change over the past year runs from −46.6% to −13.5% across the middle 80 percent of the group, with a median of −33.6%.
Other lists in this group
Table
4 of 4,095 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| SUS.ST | Surgical Science Sweden AB (publ) | $279.10M | Small cap | −48.69% | Nov 12, 2026 |
| NGEN | NervGen Pharma Corp. | $223.65M | Small cap | −8.30% | Nov 23, 2026 |
| HOWL | Werewolf Therapeutics, Inc. | $48.05M | Micro cap | −25.65% | Oct 30, 2026 |
| SKYE | Skye Bioscience, Inc. | $8.92M | Micro cap | −41.62% | Nov 9, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.